tirzepatide oral liquid A new way to lose weight, no needles required. Now offering sublingual semaglutide Compounded Oral Tirzepatide ODT: Plans

Cao S, Wang C, Yan J, Li X, Wen J, Hu C

Rare but serious risks pancreatitis, gallbladder events, severe dehydration, allergic reactions are recognised for both and are listed in the BNF and the UK Summary of Product Characteristics

The Paradox: High Obesity, Low GLP-1 Access Despite high obesity rates in underserved communities, these populations have some of the lowest access to GLP-1 medications

What the clinical trials do show is how tirzepatide performs at standard and higher doses, which gives us a framework for understanding what lower doses might achieve

Probiotics in fermented foods support the microbiota, which plays a role in GLP-1 signaling